Liver Health UK commits to support Bio-Artificial Liver Machine

New food and drink company, Liver Health UK, has partnered with The Liver Group Charity to tackle the increasing levels of non-alcoholic related liver disease in the UK and fund vital research into the development of a Bio-Artificial Liver Machine.

The company will donate a portion of its sales to the medical research charity which is focused on the development of a Bio-Artificial Liver Machine that will prove as important to the treatment of liver disease as kidney dialysis is to those with kidney failure.

A Bio-Artificial Liver Machine will enable patients with liver failure to be treated for several days, taking their blood, and passing it through the machine of liver cells, returning the ‘cleaned’ blood to the patient. This process allows the ‘real’ liver a few days necessary rest to heal itself while the machine does all the work.

Liver disease is one of the fastest growing health issues in the UK with one in three estimated to be living with a non-alcoholic fatty liver (NAFLD). With no definitive cure, the development of a Bio-Artificial Liver Machine and the introduction of preventative measures, such as small lifestyle and diet changes remain the best course of action.

Asanka De Silva, CEO of Liver Health UK, said: “Our partnership with The Liver Group Charity is all about funding research and development to improve the lives of those suffering from liver disease. Currently, 80% of people living in the UK with acute liver failure will die without a transplant.”